The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a ...

Full-year EPS for 2024 reached $10.67, up 12% comparably. IDEXX introduced key innovations, including the launch of IDEXX inVue Dx, a slide-free Point-of-Care analyzer, and the IDEXX Cancer Dx ...

Focusing its efforts on innovation, Idexx recently introduced the inVue Dx™ Cellular Analyzer to streamline veterinary workflows. With strong R&D investments, the company continues to expand its ...